Clinical trial
ABUNDANCE of A NATURAL ODOUR in HUMAN CEREBROSPINAL FLUID AFTER OLFACTORY EXPOSURE - the OLFO-Brain Study
Recruiting now · Early Phase 1 · 1 countries · Registry ID NCT06370845
What this study is about
The goal of this clinical trial is to investigate the abundance of a natural odour in human cerebrospinal fluid in obese and lean participants after inhalation thereof. Participants will undergo blood sample collection and inhalation of either a natural odour or placebo through an inhaler in addition to a liquor puncture prescribed in standard of care context.
Basic eligibility
Full registry criteria
Treatments and study arms
Inhalation - Natural Odour
Inhalation of 50 uL of a natural odour via nasal septum mini-inhaler.
Inhalation - Placebo
Inhalation of 50 uL of Placebo via nasal septum mini-inhaler.
Primary outcomes
Detection of a natural odour in human CSF within 30 min following end of an 15 min olfactory stimulation thereof compared to placebo. The presence of the Verum (natural odour) will be assessed via Gas Chromatography-Mass Spectrometry. This will be analyzed using a binary logistic regression model to determine the odds ratio of detecting a natural odour in the CSF post-stimulation. The model will account for variables such as age, sex, and BMI category (obese vs. lean). The significance level will be set at p \< 0.05.
Study locations
2 locations were listed when this page was built. The first 40 are shown.